Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV Vaccines Immunogenicity and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02979535
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 480
Early research (Phase 1)UnknownNCT05672966
What this trial is testing

Phase I Clinical Trial of a Candidate HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Wuhan BravoVax Co., Ltd. 40
Large-scale testing (Phase 3)UnknownNCT05668572
What this trial is testing

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 12,000
Large-scale testing (Phase 3)UnknownNCT04895020
What this trial is testing

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT00344032
What this trial is testing

Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 354
Large-scale testing (Phase 3)Study completedNCT01735006
What this trial is testing

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Xiamen University 7,372
Large-scale testing (Phase 3)Active Not RecruitingNCT05314023
What this trial is testing

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

Who this might be right for
Genital Warts
Merck Sharp & Dohme LLC 1,590
Not applicableStudy completedNCT00727636
What this trial is testing

Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy

Who this might be right for
Inflammatory Bowel Disease
Boston Children's Hospital 53
Large-scale testing (Phase 3)Study completedNCT00426361
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 751
Large-scale testing (Phase 3)Active Not RecruitingNCT06866574
What this trial is testing

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

Who this might be right for
Penile/Perineal /Perianal Intraepithelial NeoplasiaAnal Intraepithelial NeoplasiaPenile/Perianal/Perineal Cancer+2 more
Xiamen University 9,300
Large-scale testing (Phase 3)Study completedNCT00492544
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 100
Early research (Phase 1)Study completedNCT03900572
What this trial is testing

Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

Who this might be right for
HPV Infections
Shanghai Zerun Biotechnology Co.,Ltd 90
Not applicableActive Not RecruitingNCT02653118
What this trial is testing

Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 4,453
Large-scale testing (Phase 3)Study completedNCT00337818
What this trial is testing

Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women

Who this might be right for
Papillomavirus Type 16/18 InfectionCervical Intraepithelial Neoplasia
GlaxoSmithKline 770
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06273553
What this trial is testing

A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

Who this might be right for
Human Papillomavirus Associated Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 2/3Human Papillomavirus Type 16 Infection+1 more
RinuaGene Biotechnology Co., Ltd. 39
Large-scale testing (Phase 3)Study completedNCT00947115
What this trial is testing

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 525
Post-approval studies (Phase 4)Study completedNCT06345885
What this trial is testing

Immunogenicity and Safety of One Dose of HPV Vaccine

Who this might be right for
Human Papillomavirus Vaccines
Xiamen Innovax Biotech Co., Ltd 200
Testing effectiveness (Phase 2)UnknownNCT03947775
What this trial is testing

HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL

Who this might be right for
Anal Intraepithelial NeoplasiaAnal CancerHuman Papilloma Virus
University Health Network, Toronto 228
Large-scale testing (Phase 3)Ended earlyNCT05584332
What this trial is testing

A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerGenital WartCIN1+9 more
Shanghai Bovax Biotechnology Co., Ltd. 3,131
Large-scale testing (Phase 3)Looking for participantsNCT05027776
What this trial is testing

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 1,348
Next Page